DaYan BioMedical International Co., Ltd. Q4 2025 Financial Report
NQ Score
67/100
N1 Content Completeness
7
AI Summary (NQ-processed)
DaYan BioMedical International Co., Ltd. reported Q4 2025 basic EPS of 0.51, operating revenue of 1.895 billion, and net income after tax of 338 million.
AI analysis data is not yet available.